Sign in
Not yet taking people in GermanyPhase 1/2

PET scans to predict early response to pre-surgery treatment in non-small cell lung cancer

Tests whether PET scans can show early treatment response in adults with lung cancer.

Key facts

Who runs it
Radboud universitair medisch centrum Stichting
Where
Tübingen, GermanySee the siteAlso in 1 other country, 1 site
Registry title
PET imaging For eaRly predictiOn of respoNse to neoadjuvanT tReatment in lUNg caNcER
Status
Not yet recruiting
Phase
Phase 1/2
People taking part
40 people, planned
Started
1 Aug 2026
Expected to end
1 Aug 2028
Type of study
Interventional
Record updated
14 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with non-small cell lung cancer. It studies PET imaging to predict early how people respond to treatment given before surgery.

Age
18 years or older
Sex
Women and men can join.

Where in Germany

Also in 1 other country, 1 site

  • Universitätsklinikum TübingenTübingen, GermanyNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
PET scans to predict early response to pre-surgery treatment in non-small cell lung cancerGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
14 October 2026